logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 18 of 18 Items
Showing 1 - 18 of 18 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Measles outbreak response immunization is context-specific: insight from the recent experience of médecins sans frontières

Minetti A, Bopp C, Fermon F, Francois G, Grais RF,  et al.
2013-11-05 • PLOS Medicine
2013-11-05 • PLOS Medicine
Andrea Minetti and colleagues compare measles outbreak responses from the Democratic Republic of the Congo and Malawi and argue that outbreak response strategies should be tailored to lo...
Journal Article
|
Review

Global practices of meningococcal vaccine use and impact on invasive disease

Ali A, Jafri RZ, Messonnier N, Tevi-Benissan C, Durrheim DN,  et al.
2014-01-01 • Pathogens and Global Health
2014-01-01 • Pathogens and Global Health
A number of countries now include meningococcal vaccines in their routine immunization programs. This review focuses on different approaches to including meningococcal vaccines in countr...
Journal Article
|
Research

Use of Lot Quality Assurance Sampling (LQAS) to estimate vaccination coverage helps guide future vaccination efforts

Alberti KP, Guthmann JP, Fermon F, Nargaye KD, Grais RF
2008-03-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2008-03-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
Inadequate evaluation of vaccine coverage after mass vaccination campaigns, such as used in national measles control programmes, can lead to inappropriate public health responses. Overes...
Journal Article
|
Research

A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain

Juan-Giner A, Domicent C, Langendorf C, Roper M, Baoundoh P,  et al.
2014-09-23 • Vaccine
2014-09-23 • Vaccine
In resource-poor settings, cold chain requirements present barriers for vaccine delivery. We evaluated the immunogenicity and safety of tetanus toxoid (TT) vaccine in "Controlled Tempera...
Journal Article
|
Research

A long-lasting measles epidemic in Maroua, Cameroon 2008-2009: mass vaccination as response to the epidemic

Luquero FJ, Pham-Orsetti H, Cummings DAT, Ngaunji PE, Nimpa M,  et al.
2011-07-01 • Journal of Infectious Diseases
2011-07-01 • Journal of Infectious Diseases
A measles outbreak occurred in Maroua, Cameroon, from January 2008 to April 2009. In accordance with recent World Health Organization guidelines, an outbreak-response immunization (ORI) ...
Journal Article
|
Research

Estimating transmission intensity for a measles epidemic in Niamey, Niger: lessons for intervention

Grais RF, Ferrari MJ, Dubray C, Bjørnstad ON, Grenfell BT,  et al.
2006-09-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2006-09-01 • Transactions of the Royal Society of Tropical Medicine and Hygiene
The objective of this study is to estimate the effective reproductive ratio for the 2003-2004 measles epidemic in Niamey, Niger. Using the results of a retrospective and prospective stud...
Journal Article
|
Research

Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad

Grais RF, Dubray C, Gerstl S, Guthmann JP, Djibo A,  et al.
2007-01-01 • PLOS Medicine
2007-01-01 • PLOS Medicine
BACKGROUND: Despite the comprehensive World Health Organization (WHO)/United Nations Children's Fund (UNICEF) measles mortality-reduction strategy and the Measles Initiative, a partnersh...
Journal Article
|
Research

Local discrepancies in measles vaccination opportunities: results of population-based surveys in Sub-Saharan Africa

Grout L, Conan N, Giner AJ, Hurtado N, Fermon F,  et al.
2014-02-21 • BMC Public Health
2014-02-21 • BMC Public Health
Background: The World Health Organization recommends African children receive two doses of measles containing vaccine (MCV) through routine programs or supplemental immunization activiti...
Journal Article
|
Short Report

Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013

Gamougam K, Daugla DM, Toralta J, Ngadoua C, Fermon F,  et al.
2015-01-01 • Emerging Infectious Diseases
2015-01-01 • Emerging Infectious Diseases
In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated...
Journal Article
|
Research

Outbreak response immunisation: the experience of Chad during recurrent measles epidemics in 2005 and 2010

Guerrier G, Guerra J, Fermon F, Talkibing WB, Sekkenes J,  et al.
2011-11-11 • International Health
2011-11-11 • International Health
Journal Article
|
Research

Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia

Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F,  et al.
2004-01-01 • Tropical Medicine and International Health
2004-01-01 • Tropical Medicine and International Health
Artemisinin-based combination therapy (ACT) is one strategy recommended to increase cure rates in malaria and to contain resistance to Plasmodium falciparum. In the Maheba refugee settle...
Journal Article
|
Research

Measles in Democratic Republic of Congo: an outbreak description from Katanga, 2010--2011

Grout L, Minetti A, Hurtado N, Francois G, Fermon F,  et al.
2013-05-22 • BMC Infectious Diseases
2013-05-22 • BMC Infectious Diseases
BACKGROUND: The Democratic Republic of Congo experiences regular measles outbreaks. From September 2010, the number of suspected measles cases increased, especially in Katanga province, ...
Journal Article
|
Review

Global epidemiology of invasive meningococcal disease

Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim DN,  et al.
2013-09-10 • Population Health Metrics
2013-09-10 • Population Health Metrics
Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In countries with high endemic rates,...
Journal Article
|
Short Report

Four years of case-based surveillance of meningitis following the introduction of MenAfriVac in Moissala, Chad: lessons learned

Page AL, Coldiron ME, Gamougam K, Acyl MA, Tamadji M,  et al.
2017-12-15 • Tropical Medicine and International Health
2017-12-15 • Tropical Medicine and International Health
Journal Article
|
Research

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial

Daugla DM, Gami JP, Gamougam K, Naibei N, Mbainadji L,  et al.
2014-01-04 • Lancet
2014-01-04 • Lancet
A serogroup A meningococcal polysaccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safe...
Journal Article
|
Research

Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria

Ferrari MJ, Fermon F, Nackers F, Llosa AE, Magone C,  et al.
2014-09-05 • International Health
2014-09-05 • International Health
In 2009, a large meningitis A epidemic affected a broad region of northern Nigeria and southern Niger, resulting in more than 75 000 cases and 4000 deaths. In collaboration with state an...
Journal Article
|
Research

Outbreak of Beriberi in a Prison in Côte d'Ivoire

Ahoua L, Etienne W, Fermon F, Godain G, Brown V,  et al.
2007-09-01 • Food and Nutrition Bulletin
2007-09-01 • Food and Nutrition Bulletin
BACKGROUND: A beriberi outbreak occurred in the Maison d'Arrêt et de Correction d'Abidjan (MACA), a detention center in Abidjan, Côte d'Ivoire, between October 2002 and April 2003. OBJEC...
Journal Article
|
Research

Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics

Grais RF, De Radiguès X, Dubray C, Fermon F, Guerin PJ
2006-08-01 • Epidemiology and Infection
2006-08-01 • Epidemiology and Infection
The current WHO policy during measles outbreaks focuses on case management rather than reactive vaccination campaigns in urban areas of resource-poor countries having low vaccine coverag...